Menu Search
Equities

Medx Health Corp

MDX:CVE

Medx Health Corp

Actions
  • Price (CAD)0.055
  • Today's Change0.00 / 0.00%
  • Shares traded100.00k
  • 1 Year change-15.38%
  • Beta1.2778
Data delayed at least 15 minutes, as of Nov 13 2024 15:42 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CADIncome statement in CADView more

Year on year Medx Health Corp had revenues fall -10.68% from 510.61k to 456.09k, though the company grew net income from a loss of 5.13m to a smaller loss of 4.58m.
Gross margin39.81%
Net profit margin-983.43%
Operating margin-983.43%
Return on assets-457.43%
Return on equity--
Return on investment--
More ▼

Cash flow in CADView more

In 2023, Medx Health Corp did not generate a significant amount of cash. Cash Flow from Financing totalled 3.42m or 749.38% of revenues. In addition the company used 3.42m for operations while cash used for investing totalled .
Cash flow per share-0.016
Price/Cash flow per share--
Book value per share-0.031
Tangible book value per share-0.031
More ▼

Balance sheet in CADView more

Medx Health Corp uses little or no debt in its capital structure.
Current ratio0.0957
Quick ratio0.0492
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.